de TheG.Epidemiology of Epstein-Barr virus and associated disease in man. In: RoizmanB, ed. The herpesviruses, vol 1. London: Plenum Press, 1982:25–103.
2.
EpsteinMAAchongBG, eds. The Epstein-Barr virus. New York: Springer-Verlag, 1979:297–320.
3.
PopeJHScottWMossDJ.Human lymphoid cell transformation by Epstein-Barr virus. Nature1973;246:140–1.
4.
MontagnierLGruestJChamaretSAdaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science1984;225:63–6.
5.
SixbeyJWNedrudJGRaab-TraubNHanesRAPaganoJS.Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med1984;310:1225–30.
6.
RobinsonJSmithDNiedermanJ.Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis. Nature1980;287:334–5.
7.
YaoQYRickinsonABEpsteinMA.A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer1985;35:35–42.
8.
StrauchBAndrewsL-LSiegelNMillerG.Orpharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet1974;1:234–7.
9.
FerbasJRahmanAAtchinsonROropharyngeal excretion of Epstein-Barr virus associated with HIV seropositivity in homosexual men. IV International Congress on AIDS, Stockholm, June 1988;1:428.
10.
GreenspanDGreenspanJSConantMOral “hairy” leukoplakia in male homosexuals: Evidence of association with papillomavirus and a herpes-group virus. Lancet1984;ii:831–4.
11.
GreenspanJSGreenspanDLennetteEReplication of Epstein-Barr virus in the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. N Engl J Med1985;313:1564–71.
12.
SyrjanenSLainePHapponenRPNiemalaM.Oral hairy leukoplakia is not a specific sign of HIV infection but related to suppression in general. J Oral Pathol Med1989;18:28–31.
13.
GreenspanDGreenspanJSDeSouzaYGLevyJAUngarAM.Oral hairy leukoplakia in an HIV-negative renal transplant recipient. J Oral Pathol Med1989;18:32–4.
14.
DrijkoningenMDe Wolf-PeetersCDegreefHDesmetV.Epidermal Langerhans cells, dermal dendritic cells and keratinocytes in viral lesions of skin and mucous membranes: An immunohistochemical study. Arch Dermatol Res1988;280:220–7.
KitchenVSHelbertMLoganREBV-associated oesophageal ulcer in AIDS. Gut (in press).
17.
Friedman-KienAE.Viral origin of hairy leukoplakia. Lancet1986;ii:694.
18.
NewmanCPolkBF.Resolution of hairy leukoplakia during therapy with 9-(l-3, dihydroxy-2-propoxymethyl) guanine (DHPG). Ann Intern Med1987;107:348–50.
19.
KesslerHHBensonCHUrbanskiP.Regression of oral hairy leukoplakia during zidovudine therapy. Arch Intern Med1988;148:2490–7.
20.
RhimJSParkJBKawakamiT.Techniques for establishing human epithelial cell cultures: Sensitivity of cell lines for propagation of herpesviruses. J Virol Methods1988;21:209–22.
21.
YoungLSSixbeyJW.Epstein-Barr virus and epithelial cells: A possible role for the virus in the development of cervical carcinoma. Cancer Surv1988;7:507–18.
22.
WallaceLEMurrayRJ.Immunological aspects of the Epstein–Barr virus system. In: KleinG, ed. Advances in viral oncology, Vol. 8. New York: Raven Press, 1989;219–36.
23.
ClearyMLDorfmanRFSklarJ.Failure in immunological control of the (Epstein-Barr) virus infection. In: EpsteinMAAchongBG, eds. The Epstein-Barr virus: recent advances. London: William Heineman, 1986;163–81.
24.
AhmedTWormserGPStahlRMalignant lymphoma in a population at risk for acquired immune deficiency syndrome. Cancer1987;60:719–23.
25.
ErnbergIAltiokE.The role of Epstein-Barr virus in lymphomas of HIV-carriers. APMIS(suppl)1989;97:58–61.
26.
Hamilton-DutoitSJPallesenGKarkovJIdentification of EBV-DNA in tumour cells of AIDS-related lymphomas by in situ hybridization. Lancet1989;1:554–5.
27.
ThomasJACrawfordDH.Epstein-Barr virus associated B-cell lymphomas in AIDS and after organ transplantation. Lancet1989;i:1075–6.
28.
NeriABarrigaFKnowlesDMMagrathIDalla-FaveraR.Different regions of the immunoglobulin heavy chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitts lymphoma. Proc Natl Acad Sci1988;85:2748–52.
29.
EpsteinMAAchongBG.The relationship of the (Epstein-Barr) virus to Burkitt's lymphoma. In: EpsteinMAAchongBG, eds. The Epstein–Barr virus. New York: Springer-Verlag, 1979;322–37.
30.
MunroAJStewartJS.AIDS: Incidence and management of malignant disease. Radiother Oncol1989;14:121–31.
31.
KenneySKamineJMarkovitzDFenwickRPaganoJ.An Epstein-Barr virus immediate early gene product trans-activates gene expression from the HIV long terminal repeat. Proc Natl Acad Sci1988;85:1652–56.
32.
SiegelLJRatnerLJosephsSFTrans-activation induced by human T-lymphotropic virus type III (HTLV-III) maps to viral sequence encoding 58 amino acids and lacks tissue specificity. Virology1986;148:226–31.
33.
DalgleishAGBeverleyPCLClapharnPRThe CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature1984;312:763–7.
34.
HoDDRotaTRHirschMS.Infection of monocyte/macrophages by human T lymphotropic virus type III. Br J Clin Invest1986;77:1712–15.
35.
YoungLSClarkDSixbeyJWRickinsonAB.Epstein–Barr receptors on human pharyngeal epithelia. Lancet1986;1:240–2.
36.
FingerothJDWeisJJTedderTFStromingerJLBiroPAFearonDT.Epstein–Barr virus receptor of human B lymphocytes is the C3d receptor. Proc Natl Acad Sci1984;81:4510–15.
37.
HarabuchiYYamanakaNKatauraAEpstein–Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet1990;335:128–30.
38.
JonesJFShurinSAbramowskyCT-cell lymphomas containing Epstein–Barr viral DNA in patients with chronic Epstein–Barr virus infections. N Engl J Med1988;318:733–41.
39.
KikutaHTaguchiYTomizawaKEpstein–Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with kawasaki-like disease. Nature1988;333:455–7.
40.
StevensonMVolskyBHedenskogMVolskyD.Immortalisation of human T lymphocytes after transfection of Epstein–Barr virus DNA. Science1986;233:980–94.
41.
WebsterALeeCACookDGCytomegalovirus infection and progress towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet1989;11:63–5.
